Chronic Low Back Pain – Buprenorphine Injection

We would like to inform you of a clinical research study that might interest you. This study is looking for patients 18‐75 years of age who have had a recent history of moderate to severe chronic low back pain (CLBP) for at least 3 months, who have been on a stable dose of opioid medication for at least 14 days to control their pain and may be looking to try a new option for pain management.

Management of chronic low back pain may be achieved through several methods, including opioid medications. Despite their proven effectiveness at reducing pain, the use of opioids are often limited due to concerns regarding safety, how they are tolerated, and concerns over drug abuse and other prohibited activity that may arise with long‐term treatment therapy for persistent pain.

The purpose of the clinical research study is to evaluate the investigational study medication (CAM2038) as weekly or monthly buprenorphine injections compared to placebo.

Participation in the clinical research study is completely voluntary and may last up to 7 months. If you are eligible to be in the study, you will receive all study‐related tests, procedures and medication or placebo (no active drug) as well as additional rescue medication pills at no cost to you. There are additional requirements to be in the study that will be discussed with you to determine if you are eligible to participate.

Please click on this link to review study information: